Adenoviral vectors primarily induce anti-tumor responses via cGAS–STING pathway activation and the induction of immunogenic cell death (e.g., ONCOS-102, which achieved a 70% tumor shrinkage rate), as well as through dual co-stimulatory mechanisms (e.g., LOAd703). Here, CGAS is linked to neoplasm.